EP Patent

EP3301094A1 — Heterocyclic compounds and their use in preventing or treating bacterial infections

Assigned to Mutabilis SA · Expires 2018-04-04 · 8y expired

What this patent protects

The invention relates to a compound of formula (I) and a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.

USPTO Abstract

The invention relates to a compound of formula (I) and a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP3301094A1
Jurisdiction
EP
Classification
—
Expires
2018-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Mutabilis SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.